THOUSAND OAKS, Calif.,
Jan. 9, 2020 /PRNewswire/ -- Amgen
(NASDAQ:AMGN) will present at the 38th Annual
J.P. Morgan Healthcare Conference
at 8:30 a.m. PT on Tuesday, Jan. 14, 2020,
in San Francisco. Robert A.
Bradway, chairman and chief executive
officer at Amgen, will present at the
conference. Live audio of the presentation can be accessed
from the Events Calendar on Amgen's website, www.amgen.com,
under Investors. A replay of the webcast will also be
available on Amgen's website for at least 90 days
following the event.
About Amgen
Amgen is committed to
unlocking the potential of biology for patients suffering from
serious illnesses by discovering, developing, manufacturing and
delivering innovative human therapeutics. This approach begins by
using tools like advanced human genetics to unravel the
complexities of disease and understand the fundamentals of human
biology.
Amgen focuses on areas of high unmet medical need and leverages
its expertise to strive for solutions that improve health outcomes
and dramatically improve people's lives. A biotechnology pioneer
since 1980, Amgen has grown to be one of the
world's leading independent biotechnology companies, has
reached millions of patients around the world and is developing a
pipeline of medicines with breakaway potential.
For more information, visit www.amgen.com and follow
us on www.twitter.com/amgen.
CONTACT: Amgen, Thousand Oaks
Jessica Akopyan, 805-447-0974
(media)
Trish Hawkins,
805-447-5631(media)
Arvind Sood, 805-447-1060
(investors)
View original content to download
multimedia:http://www.prnewswire.com/news-releases/amgen-to-present-at-the-38th-annual-jp-morgan-healthcare-conference-300984535.html
SOURCE Amgen